Centrus Q3 Net Income Jumps 710% on $46.4M Warrant Gain

# Centrus Q3 Net Income Jumps 710% on $46.4M Warrant Gain

Centrus Energy Corp. (NYSE: LEU) reported third-quarter 2026 net income of $31.6 million on 4 November 2026, up 710% from $3.9 million a year earlier, even as revenue fell 26% to $55.5 million. The GAAP profit rested almost entirely on a $46.4 million non-cash gain from revaluing warrant liabilities. Strip that out, and the company posted a non-GAAP adjusted net loss of $9.4 million, or $0.46 per share, versus adjusted net income of $5.2 million in Q3 2025.

Context — why this matters now

Centrus sells two things: enriched uranium fuel under its LEU segment, and engineering and production services under Technical Solutions. The headline net income number tells you almost nothing about either. The warrant gain is an accounting adjustment tied to derivatives on the balance sheet, not cash from customers, and the company itself flags the adjusted figure as the cleaner read on operations.

That adjusted figure went from positive $5.2 million to negative $9.4 million in twelve months. The swing traces to two lines. Gross loss widened to $10.6 million from $4.3 million, a 147% deterioration. And the Technical Solutions segment flipped from a $3.5 million gross profit to a $3.7 million gross loss, a $7.2 million reversal the company attributes to its HALEU Operation Contract with the Department of Energy.

That contract is the catalyst chain worth tracking. Centrus signed it in 2022 to produce high-assay low-enriched uranium, or HALEU, for DOE. Revenue from that contract fell $10.2 million quarter over quarter. Separately, the company said DOE has communicated it does not currently intend to exercise further options under the agreement, and the budget proposed for fiscal 2027 contains no further funding for operating the HALEU cascade.

For a company whose commercial story rests on scaling enrichment capacity, losing a government anchor customer is a material development. Centrus is now leaning harder on private-sector demand to fill that gap, and its backlog disclosures show how it intends to do so.

The broader rate backdrop matters less here than contract structure. Centrus carries multi-year customer agreements rather than quarterly commitments, which the company says makes quarterly revenue lumpy by design.

Data — what the numbers show

Total revenue fell to $55.5 million from $74.9 million, a decline of $19.4 million or 26%. The LEU segment contributed $31.8 million, down 29%, and Technical Solutions contributed $23.7 million, down 21%.

Within LEU, the mix shifted sharply. Uranium revenue dropped $16.4 million on lower volumes sold, while separative work units, or SWU, revenue rose $3.4 million on a 19% volume increase and a 10% higher average price. SWU is the unit of enrichment work; uranium is the raw material. Rising SWU pricing with falling uranium volumes points to a customer base buying enrichment rather than metal.

Metric	Q3 2026	Q3 2025	Change
Total revenue	$55.5M	$74.9M	-26%
Gross loss	$10.6M	$4.3M	+147%
GAAP net income	$31.6M	$3.9M	+710%
Adjusted net income (loss)	-$9.4M	$5.2M	n/a
Diluted EPS	$1.41	$0.19	+642%

The cost side cut the other way. LEU cost of sales fell 26% to $38.7 million, but SWU unit costs climbed 28% even as volumes rose 19%. Technical Solutions cost of sales rose 3% to $27.4 million, driven by customer contract costs that a $1.7 million drop in HALEU contract costs only partly offset.

Backlog is the offsetting positive. Total backlog across both segments stands at $7.0 billion as of 30 September 2026 and extends to 2040. The LEU segment accounts for roughly $6.2 billion of that, including $5.4 billion in contingent LEU and HALEU sales commitments, $5.1 billion of which sit under definitive agreements. Technical Solutions backlog is about $0.8 billion — and the company notes the entire $0.8 billion is tied to the HALEU Operation Contract that DOE is not currently funding.

Nine-month figures show the same tension at larger scale: revenue of $308.3 million against $302.5 million a year earlier, gross profit of $70.8 million versus $82.5 million, and adjusted net income of $52.8 million versus $68.3 million.

Analysis — what it means for markets

The cleanest read on Centrus is that its earnings quality diverged from its earnings headline this quarter. GAAP net income of $31.6 million sits alongside an operating loss of $29.7 million. Advanced technology costs quadrupled to $4.7 million from $1.7 million, and selling, general and administrative expenses rose $3.7 million to $13.2 million. Those are the costs of building a centrifuge supply chain before the revenue arrives.

The company is spending ahead of the curve deliberately. Management said it completed manufacturing of its first centrifuge and began shipping units from Oak Ridge, Tennessee, ahead of its year-end target, and finalized contracts with all supply-chain partners it deemed critical. CEO Amir Vexler said the supply chain is "unobligated," which the company frames as allowing it to serve both national security and commercial markets.

Sector exposure runs through the nuclear fuel complex. Utilities that signed long-term SWU contracts have visibility into pricing but face the same lumpy delivery schedule Centrus describes. Enrichment competitors pursuing Western capacity face a rival that just moved first on manufacturing.

The counter-argument deserves weight. Centrus lost its anchor HALEU customer in DOE, and the $5.4 billion contingent backlog depends on hitting operational milestones that have not yet been met. Contingent commitments are not revenue. The $5.1 billion under definitive agreements narrows the gap, but the company has not disclosed delivery schedules or pricing for those contracts.

Positioning reflects that split. The warrant liability revaluation implies holders of those instruments saw their claims move against them as the stock or underlying terms shifted, generating Centrus's gain. Investors buying the GAAP beat are buying an accounting event; investors focused on adjusted results are looking at a company still in investment mode.

Outlook — what to watch next

Centrus updated full-year 2026 guidance. It expects total revenue of $450 million to $500 million and total capital deployment of $350 million to $500 million, driven by its centrifuge manufacturing build-out. Both figures are company expectations, not results.

On hiring, the company targets at least 100 net new employees at Oak Ridge and at least 175 at Piketon, Ohio, raised from a prior target of 100. Those are the operational markers of the expansion it says is running two months ahead of schedule.

Three things resolve the story from here. First, whether any commercial HALEU customer replaces the DOE volume. Second, whether the contingent $5.4 billion backlog converts to definitive agreements as milestones are hit. Third, how DOE's fiscal 2027 budget process treats the HALEU cascade.

Centrus shares trade on the NYSE under LEU. The company did not disclose the terms of its recent Westerman acquisition in the release.

Frequently Asked Questions

Why did Centrus report a $31.6 million profit but a $9.4 million adjusted loss?

The $31.6 million GAAP net income includes a $46.4 million non-cash gain from revaluing warrant liabilities, which is an accounting adjustment rather than customer revenue. Excluding that gain, plus growth costs and stock-based compensation, Centrus reported an adjusted net loss of $9.4 million, or $0.46 per share. The company presents the adjusted figure as the better measure of ongoing operations.